Web Results

Plerixafor - Wikipedia


Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients ... ball-and-stick model.png. Clinical data. Trade names, Mozobil.



Official site from Genzyme Corporation. Contains consumer and prescribing information.

Why Mozobil? | Mozobil (plerixafor injection)


Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

Billing and Reimbursement | Mozobil (plerixafor injection)


Learn how you can order and be reimbursed for Mozobil (plerixafor injection). Please see Important Safety Information.

Mozobil (plerixafor) Uses, Dosage, Side Effects - Drugs.com


Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions ...

Mozobil (Plerixafor Injection): Side Effects, Interactions, Warning ...


Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...

Common Side Effects of Mozobil (Plerixafor Injection) Drug Center ...


Aug 27, 2015 ... Find a comprehensive guide to possible side effects including common and rare side effects when taking Mozobil (Plerixafor Injection) for ...

Mozobil (plerixafor) injection label - FDA


MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ... Initiate Mozobil treatment after the patient has received G-CSF once daily for 4 days.

Mozobil (plerixafor) dosing, indications, interactions, adverse effects ...


Medscape - Indication-specific dosing for Mozobil (plerixafor), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

Mozobil - European Medicines Agency - Europa


Mozobil 20 mg/ml solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One ml of solution contains 20 mg plerixafor. Each vial contains  ...